These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6768092)

  • 1. An evaluation of the young dopamine-lesioned rat as an animal model for minimal brain dysfunction (MBD).
    Thieme RE; Dijkstra H; Stoof JC
    Psychopharmacology (Berl); 1980 Feb; 67(2):165-9. PubMed ID: 6768092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereotyped behaviour patterns and hyperactivity induced by amphetamine and apomorphine after discrete 6-hydroxydopamine lesions of extrapyramidal and mesolimbic nuclei.
    Castall B; Marsden CD; Naylor RJ; Pycock CJ
    Brain Res; 1977 Mar; 123(1):89-111. PubMed ID: 300267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraventricular 6-hydroxydopamine in the newborn rat and locomotor responses to drugs in infancy: no support for the dopamine depletion model of minimal brain dysfunction.
    Pappas BA; Gallivan JV; Dugas T; Saari M; Ings R
    Psychopharmacology (Berl); 1980; 70(1):41-6. PubMed ID: 6775333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in the behavioral response to a novel environment following lesioning of the central dopaminergic system in rat pups.
    Stoof JC; Duijkstra H; Hillegers JP
    Psychopharmacology (Berl); 1978 Apr; 57(2):163-6. PubMed ID: 418450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caffeine improves attention deficit in neonatal 6-OHDA lesioned rats, an animal model of attention deficit hyperactivity disorder (ADHD).
    Caballero M; Núñez F; Ahern S; Cuffí ML; Carbonell L; Sánchez S; Fernández-Dueñas V; Ciruela F
    Neurosci Lett; 2011 Apr; 494(1):44-8. PubMed ID: 21362462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain.
    Costall B; Marsden CD; Naylor RJ; Pycock CJ
    Brain Res; 1976 Dec; 118(1):87-113. PubMed ID: 990957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rat model for attention deficit-hyperactivity disorder.
    Kohlert JG; Bloch GJ
    Physiol Behav; 1993 Jun; 53(6):1215-8. PubMed ID: 8346308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective brain dopamine depletion in developing rats: an experimental model of minimal brain dysfunction.
    Shaywitz BA; Yager RD; Klopper JH
    Science; 1976 Jan; 191(4224):305-8. PubMed ID: 942800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral effects of amphetamine and apomorphine after striatal lesions in the rat.
    Antoniou K; Kafetzopoulos E
    Pharmacol Biochem Behav; 1992 Nov; 43(3):705-22. PubMed ID: 1448467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral effects of a lesion in the ventral mesencephalic tegmentum: evidence for involvement of A10 dopaminergic neurons.
    Le Moal M; Stinus L; Simon H; Tassin JP; Thierry AM; Blanc G; Glowinski J; Cardo B
    Adv Biochem Psychopharmacol; 1977; 16():237-45. PubMed ID: 883544
    [No Abstract]   [Full Text] [Related]  

  • 11. Paradoxical effects of amphetamine on preweanling and postweanling rats.
    Campbell BA; Randall PJ
    Science; 1977 Mar; 195(4281):888-91. PubMed ID: 557236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Behavioral evaluation of the unilateral lesion model in rats using 6-hydroxydopamine. Correlation between the rotations induced by D-amphetamine, apomorphine and the manual dexterity test].
    Pavón N; Vidal L; Alvarez P; Blanco L; Torres A; Rodríguez A; Macías R
    Rev Neurol; 1998 Jun; 26(154):915-8. PubMed ID: 9658459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dopaminergic agonists and antagonists of feeding in intact and 6-hydroxydopamine-treated rats.
    Heffner TG; Zigmond MJ; Stricker EM
    J Pharmacol Exp Ther; 1977 May; 201(2):386-99. PubMed ID: 859104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockage of amphetamine induced motor stimulation and stereotypy in the adult rat following neonatal treatment with 6-hydroxydopamine.
    Creese I; Iversen SD
    Brain Res; 1973 Jun; 55(2):369-82. PubMed ID: 4145950
    [No Abstract]   [Full Text] [Related]  

  • 15. Anatomical analysis of the involvement of mesolimbocortical dopamine in the locomotor stimulant actions of d-amphetamine and apomorphine.
    Clarke PB; Jakubovic A; Fibiger HC
    Psychopharmacology (Berl); 1988; 96(4):511-20. PubMed ID: 3149775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dopamine D4 receptor is essential for hyperactivity and impaired behavioral inhibition in a mouse model of attention deficit/hyperactivity disorder.
    Avale ME; Falzone TL; Gelman DM; Low MJ; Grandy DK; Rubinstein M
    Mol Psychiatry; 2004 Jul; 9(7):718-26. PubMed ID: 14699433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proceedings: Behavioral effects of direct and indirect acting dopaminergic agonists.
    Moore KE
    Psychopharmacol Bull; 1974 Jul; 10(3):41-2. PubMed ID: 4419323
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuropharmacological basis of stimulant drug action in attention deficit disorder with hyperactivity: a review and synthesis.
    Solanto MV
    Psychol Bull; 1984 May; 95(3):387-409. PubMed ID: 6152684
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of d-amphetamine and apomorphine upon operant behavior and schedule-induced licking in rats with 6-hydroxydopamine-induced lesions of the nucleus accumbens.
    Robbins TW; Roberts DC; Koob GF
    J Pharmacol Exp Ther; 1983 Mar; 224(3):662-73. PubMed ID: 6402587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An observational method for quantifying the behavioural effects of dopamine agonists: contrasting effects of d-amphetamine and apomorphine.
    Fray PJ; Sahakian BJ; Robbins TW; Koob GF; Iversen SD
    Psychopharmacology (Berl); 1980; 69(3):253-9. PubMed ID: 6774363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.